𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Somatostatin cerebrospinal fluid levels in dementia

✍ Scribed by A. Molins; R. Catalán; J. Sahuquillo; J. M. Castellanos; A. Codina; R. Galard

Publisher
Springer
Year
1991
Tongue
English
Weight
358 KB
Volume
238
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

✦ Synopsis

Somatostatin levels were measured in cerebrospinal fluid of patients with Alzheimer's disease, multi-infarct dementia and normal pressure hydrocephalus and compared with levels from a normal control group. All pathological groups showed a statistically significant decrease of somatostatin with respect to the control group, but no significant differences were found amongst them. A negative correlation was found between the Mini Mental State Test and the somatostatin levels in Alzheimer's disease patients but not in the other groups. Our results confirm that the lower levels of somatostatin in cerebrospinal fluid are not specific to Alzheimer's disease and indicate that the decrease found in all the groups is probably the result of neuronal destruction or damage in the diseases examined.

📜 SIMILAR VOLUMES

Altered levels of cerebrospinal fluid re
Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease
✍ Javier Sáez-Valero; Mercedes Costell; Magnus Sjögren; Niels Andreasen; Kaj Blenn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract Reelin is an essential glycoprotein for correct cytoarchitectonic organization during CNS development. Its function in the adult brain is far less well understood, but altered brain and blood reelin levels have been reported in some psychiatric disorders, and the possibility has been co

Somatostatin-like immunoreactivity in th
Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients
✍ J. Kohler; E. Schröter; H. Cramer 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 366 KB

Using a specific radioimmunoassay we have measured somatostatin-like immunoreactivity (SLIR) of CSF in patients with brain atrophy, spinal spasticity, seizures, brain tumors and inflammatory disorders. Patients with marked brain atrophy had significantly decreased somatostatin levels in CSF. In pati

Cerebrospinal fluid corticotropin-releas
Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the alzheimer type
✍ Emilia Martignoni; Alfredo Costa; Giuseppe Nappi; Felice Petraglia; Anna Monzani 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

Experimental findings have recently suggested a toxic role for glucocorticoids in hippocampus, the main brain target for the adrenocortical hormones. In this study, we explored the activity of the hypothalamuspituitary-adrenal (HPA) axis in a group of patients with dementia of the Alzheimer's type (